In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...
Projects include advancing control strategies against common hog industry diseases, helping humans by increasing the use of ...
Active rash, interstitial lung disease and elevated neutrophil to lymphocyte ratio were independently associated with ...
A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...
Full MIST2 dosing of intrapleural enzyme therapy varies widely across hospitals and is associated with a lower risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback